Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126306931 | 12630693 | 1 | I | 20160629 | 20160728 | 20160808 | 20160808 | EXP | GB-MHRA-TPP13137043C3821036YC1469016278613 | GB-ELI_LILLY_AND_COMPANY-GB201607012753 | ELI LILLY AND CO | 44.00 | YR | F | Y | 77.00000 | KG | 20160808 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126306931 | 12630693 | 1 | PS | TRULICITY | DULAGLUTIDE | 1 | Unknown | UNK UNK, UNKNOWN | Y | U | 125469 | INJECTION | |||||||
| 126306931 | 12630693 | 2 | SS | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 2 DF, QD | 989.917 | DF | U | U | 0 | 2 | DF | QD | |||
| 126306931 | 12630693 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 1 DF, QD | 744 | DF | 0 | 1 | DF | QD | |||||
| 126306931 | 12630693 | 4 | C | CERELLE | DESOGESTREL | 1 | 1 DF, QD | 69 | DF | 0 | 1 | DF | QD | ||||||
| 126306931 | 12630693 | 5 | C | EMPAGLIFLOZIN | EMPAGLIFLOZIN | 1 | 1 DF, QD | 21 | DF | 0 | 1 | DF | QD | ||||||
| 126306931 | 12630693 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 1 DF, TID | 500.875 | DF | 0 | 1 | DF | TID | ||||||
| 126306931 | 12630693 | 7 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | USE AS DIRECTED. | 0 | |||||||||||
| 126306931 | 12630693 | 8 | C | LIXISENATIDE | LIXISENATIDE | 1 | USE AS DIRECTED. | 0 | |||||||||||
| 126306931 | 12630693 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 4 DF, QD | 547.833 | DF | 0 | 4 | DF | QD | |||||
| 126306931 | 12630693 | 10 | C | TRANEXAMIC ACID. | TRANEXAMIC ACID | 1 | Oral | 2 DF, UNK | 0 | 2 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126306931 | 12630693 | 1 | Product used for unknown indication |
| 126306931 | 12630693 | 2 | Product used for unknown indication |
| 126306931 | 12630693 | 3 | Blood cholesterol |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126306931 | 12630693 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126306931 | 12630693 | Depressed mood | |
| 126306931 | 12630693 | Dyspepsia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126306931 | 12630693 | 1 | 20160626 | 20160708 | 0 | |
| 126306931 | 12630693 | 2 | 20150220 | 0 | ||
| 126306931 | 12630693 | 3 | 20140616 | 0 | ||
| 126306931 | 12630693 | 4 | 20160421 | 20160714 | 0 | |
| 126306931 | 12630693 | 5 | 20160720 | 0 | ||
| 126306931 | 12630693 | 6 | 20160114 | 0 | ||
| 126306931 | 12630693 | 7 | 20160720 | 0 | ||
| 126306931 | 12630693 | 8 | 20151211 | 0 | ||
| 126306931 | 12630693 | 9 | 20160213 | 0 | ||
| 126306931 | 12630693 | 10 | 20140317 | 0 |